全球短期机械循环系统市场规模（按产品、治疗方法、最终用户、区域范围和预测）

短期机械循环系统的市场规模及预测

2024 年短期机械循环系统市场规模价值 20.783 亿美元，预计到 2032 年将达到 48.7299 亿美元，在 2026-2032 年预测期内的复合年增长率为 11.24%。

推动全球短期机械循环系统市场的因素

短期机械循环系统市场的驱动因素可能受到多种因素的影响。这些因素包括：

人口老化：随着世界人口老化，心臟衰竭等心血管疾病的发生率不断上升。老年人体质虚弱，如果有心臟问题，可能需要机械循环系统支持。

生活型态因素：心血管疾病（CVD）盛行率的上升是由于久坐不动的生活型态、不良饮食、吸烟和肥胖的增加，需要加强MCS等替代治疗方法。

创新设备：医疗技术不断发展，带来更小、更容易插入且更有效率的 MCS 设备。这些发展正在扩大 MCS 在临床实践中的应用，并改善患者的治疗效果。

提高安全性和耐用性：提高生物相容性、降低併发症发生率和延长设备寿命导致 MCS 设备的使用量迅速增加。

移植和復健的桥樑：对于患有终末期心臟衰竭的患者，MCS 设备是心臟移植的重要桥樑，同时还可在心血管手术或突发心臟危机后的恢復期间提供短期支持。

适应症不断扩大：由于 MCS 的临床适应症不断扩大，包括心源性休克和高经皮经皮冠状动脉介入治疗 (PCI) 患者，市场也在不断扩大。

医疗保健支出：成熟市场和新兴市场的医疗保健支出不断增加，推动了对 MCS 等尖端医疗技术的投资增加。

覆盖范围和报销：改进的覆盖范围和报销指南使患者更容易获得 MCS 程序和设备。

支持监管核准和良好的法规环境：为了促进市场进入和成长，FDA 和 EMA 等监管机构正在为新的 MCS 设备提供更有效率的核准程序。

临床研究和证据：临床研究的积极结果和越来越多的临床证据证明 MCS 设备的有效性，从而提高了医生的信心和采用率。

市场动态：主要企业和竞争格局：创新和市场成长受到现有市场参与者对研发和策略伙伴关係的投资所推动。

全球扩张：渗透新市场和扩大分销网络将增加市场潜力。

患者接受度和意识宣传活动：加强向患者和医疗保健专业人员宣传心臟衰竭治疗和 MCS 选项，将提高采用率。

患者结果和生活品质：MCS 支持已被证明可以改善患者结果和生活质量，鼓励接受和使用这些设备。

限制全球短期机械循环系统市场的因素

短期内，机械循环系统市场可能面临多种限製或挑战，包括：

设备成本：MCS 设备价格昂贵，且与设备相关的初始成本相当高。

营运成本：使用这些仪器的成本因使用这些仪器相关的营运成本而增加，例如消耗品、维护和对专业人员的需求。

医疗保健预算限制：许多医疗保健系统，尤其是低度开发国家，发现难以资助昂贵的 MCS 治疗。

技术复杂性：MCS 设备的安装和维护需要先进的医疗保健基础设施和高素质的医疗专业人员。

对患者的风险：出血、感染和装置相关併发症的高风险可能会阻止患者使用这些治疗方法。

监管障碍：获得新 MCS 设备的监管核准既费时又昂贵，而且不同地区的监管要求存在差异，这又增加了复杂性。

上市后监测：为了监测其设备的有效性和安全性，製造商必须进行彻底且通常耗费大量资源的上市后调查计画。

保险范围：MCS 疗法费用昂贵，因此有些保险公司不愿意承保，而且报销规则各不相同。

报销率：医院和临床医生采用这些技术的意愿可能会受到报销率的影响，而报销率（如果适用）可能不足以抵消这些成本。

缺乏知识：医疗保健专业人员可能没有充分了解 MCS 设备的最新发展和优势。

所需培训：医疗保健专业人员必须接受大量培训才能正确使用 MCS 设备，这在无法获得专门培训计划的地区可能会很困难。

激烈的竞争：许多公司正在争夺大量市场份额，这可能导致价格压力和持续创新的需求。

科技进步迅速：科技的快速进步需要持续的研发投入，这对企业，尤其是中小企业带来资金压力。

经济不确定性：医疗保健支出和对尖端医疗技术的投资可能会受到某些地区景气衰退和金融不稳定的影响。

地缘政治不确定性：医疗设备市场和供应链动态可能会受到地缘政治变数的影响，例如贸易限制和政治不稳定。

目录

第一章 引言

• 市场定义
• 市场区隔
• 调查方法

第二章执行摘要

• 主要发现
• 市场概览
• 市集亮点

第三章市场概述

• 市场规模和成长潜力
• 市场趋势
• 市场驱动因素
• 市场限制
• 市场机会
• 波特五力分析

第四章 短期机械流通市场：依产品

• 主动脉内球囊帮浦（IABP）
• 经皮辅助人工心臟（pVAD）
• 体外膜氧气疗法（ECMO）
• 其他设备

第五章短期机械自行车市场：治疗方法

• 心源性休克
• 急性心臟衰竭
• 术后支持

第六章 短期机械流通市场（依最终使用者）

• 医院
• 门诊手术中心
• 专科诊所

第七章区域分析

• 北美洲
• 美国
• 加拿大
• 墨西哥
• 欧洲
• 英国
• 德国
• 法国
• 义大利
• 亚太地区
• 中国
• 日本
• 印度
• 澳洲
• 拉丁美洲
• 巴西
• 阿根廷
• 智利
• 中东和非洲
• 南非
• 沙乌地阿拉伯
• 阿拉伯聯合大公国

第八章市场动态

• 市场驱动因素
• 市场限制
• 市场机会
• COVID-19 市场影响

第九章 竞争态势

• 主要企业
• 市场占有率分析

第十章 公司简介

• Abiomed
• Medtronic
• SynCardia
• Berlin Heart GmbH
• CardiacAssist Inc.
• Jarvik Heart Inc.
• MicroMed Cardiovascular Inc.
• ReliantHeart Inc.
• Thoratec Corporation
• CHF Solutions

第十一章 市场展望与机会

• 新兴技术
• 未来市场趋势
• 投资机会

第十二章 附录

• 简称列表
• 来源和参考文献

Short Term Mechanical Circulatory Market Size And Forecast

Short Term Mechanical Circulatory Market size was valued at USD 2078.3 Million in 2024 and is projected to reach USD 4872.99 Million by 2032, growing at a CAGR of 11.24% during the forecast period 2026-2032.

Global Short Term Mechanical Circulatory Market Drivers

The market drivers for the Short Term Mechanical Circulatory Market can be influenced by various factors. These may include:

Population Ageing: The prevalence of cardiovascular disorders, such as heart failure, is increasing as the world's population ages. Due to their increased vulnerability, older persons may need mechanical circulatory support if they have heart problems.

Lifestyle Factors: The increased incidence of CVDs is attributed to the rise of sedentary lifestyles, poor diets, smoking, and obesity, which calls for enhanced treatment alternatives like MCS.

Innovative Devices: Medical technology is constantly evolving, and this has resulted in the development of MCS devices that are smaller, less intrusive, and more effective. These developments increase the application of MCS in clinical settings and enhance patient outcomes.

Better Safety and Durability: MCS device usage has surged due to improved biocompatibility, lower complication rates, and longer-lasting devices.

Bridge to Transplant and Rehab: For patients with end-stage heart failure, MCS devices are an essential bridge to a heart transplant. Additionally, they offer short-term assistance while recovering from heart surgery or sudden cardiac crises.

Expanded Indications: The market is growing because to the growing list of clinical indications for MCS, which includes patients with cardiogenic shock and high-risk percutaneous coronary procedures (PCI).

Healthcare Spending: More money is being invested in cutting-edge medical technology, such as MCS, as a result of rising healthcare spending in both established and emerging markets.

Insurance Coverage and Reimbursement: Patients can now access MCS procedures and equipment more easily thanks to improved insurance coverage and reimbursement guidelines.

Regulatory Approvals and Support Good Regulatory Environment: To promote market entry and growth, regulatory organisations like the FDA and EMA are offering more efficient clearance procedures for novel MCS devices.

Clinical studies and Evidence: Physician confidence and adoption rates are increased by the positive results of clinical studies and the expanding body of clinical evidence demonstrating the effectiveness of MCS devices.

Market Dynamics: Key Players and Competitive Landscape: Innovation and market growth are propelled by the presence of well-established market players who invest in R&D and strategic alliances.

Global Reach: Market potential are improved by growing market penetration in new markets and enlarging distribution networks.

Campaigns to Increase Patient Acceptance and Awareness: Higher adoption rates are a result of increased efforts to educate patients and healthcare professionals about heart failure treatments and MCS choices.

Patient Outcomes and Quality of Life: Acceptance and usage of these devices are encouraged by shown improvements in patient outcomes and quality of life with MCS support.

Global Short Term Mechanical Circulatory Market Restraints

Several factors can act as restraints or challenges for the Short Term Mechanical Circulatory Market. These may include:

Cost of Device: MCS devices are costly, with significant up-front expenditures associated with the equipment.

Operational Costs: The cost of using these devices is increased by the operational costs related to their use, which include disposables, maintenance, and the requirement for specialised personnel.

Healthcare Budget Restraints: It might be difficult to allocate funds for pricey MCS therapy in many healthcare systems, particularly in underdeveloped nations.

Technical Complexity: Advanced healthcare infrastructure and highly qualified medical professionals are needed for the installation and maintenance of MCS devices.

Patient Risk: The use of these treatments may be discouraged due to the high risks involved, which include bleeding, infection, and complications related to the devices.

Regulatory Obstacles: It can take a while and be expensive to get regulatory approval for new MCS devices. The intricacy is increased by regional variations in regulatory requirements.

Post-Market Surveillance: To keep an eye on the effectiveness and safety of their devices, manufacturers must conduct a thorough, often resource-intensive, post-market surveillance programme.

Insurance Coverage: Due to the high expense of MCS therapies, several insurers are hesitant to pay for them. Reimbursement rules for these therapies might be uneven.

Reimbursement Rates: Hospital and clinician desire to embrace these technologies may be impacted by reimbursement rates, which, even in cases where they are covered, may not adequately offset the costs involved.

Lack of Knowledge: Healthcare professionals may not be fully informed about the most recent developments and advantages of MCS equipment.

Training Requirements: In order to use MCS devices properly, medical practitioners must undergo extensive training, which can be a challenge in areas with limited access to specialised training programmes.

Fierce Competition: A number of businesses are fighting for a larger part of the market. Pricing pressures and the requirement for ongoing innovation may result from this.

Fast Technological improvements: Investing continuously in R&D is necessary due to the rapid improvements in technology, and this can put a financial pressure on businesses, particularly smaller ones.

Economic Instability: Healthcare spending and investments in cutting-edge medical technologies may be impacted by economic downturns and financial instability in some areas.

Geopolitical Uncertainty: The dynamics of the MCS device market and supply chain may be impacted by geopolitical variables like as trade restrictions and political unrest.

Global Short Term Mechanical Circulatory Market Segmentation Analysis

The Global Short Term Mechanical Circulatory Market is Segmented on the basis of Product, Therapy, End-User, And Geography.

Short Term Mechanical Circulatory Market, By Product

• Intra-aortic Balloon Pumps (IABPs): These minimally invasive devices are inserted into the aorta, the main artery leaving the heart. A small balloon inflates and deflates with each heartbeat, helping to improve blood flow throughout the body and reduce workload on the heart. They are typically used for short-term support in patients experiencing cardiogenic shock or heart failure.
• Percutaneous Ventricular Assist Devices (pVADs): These compact pumps are inserted directly into the heart or a nearby blood vessel. They take over some or all of the heart's pumping function, providing temporary circulatory support. pVADs are used for a wider range of situations compared to IABPs, including bridge to transplant, bridge to decision (allowing time for further evaluation), and destination therapy (long-term support for patients ineligible for transplant).
• Extracorporeal Membrane Oxygenation (ECMO): This technique involves using a heart-lung bypass machine to provide temporary support for both the heart and lungs. Blood is removed from the body, oxygenated, and then returned, essentially taking over the function of these vital organs. ECMO is used in critically ill patients with severe respiratory or cardiac failure.
• Other Devices: This category includes emerging technologies and niche products within the short-term mechanical circulatory support market. Examples might be Impella devices (specialized pVADs) or ventricular unloading devices.

Short Term Mechanical Circulatory Market, By Therapy

• Cardiogenic Shock: This is a life-threatening condition where the heart is unable to pump enough blood to meet the body's needs. Short-term mechanical circulatory support plays a crucial role in stabilizing these patients and improving their chances of recovery.
• Acute Heart Failure: A sudden worsening of heart failure symptoms can necessitate temporary mechanical support to bridge patients to definitive treatment or recovery.
• Post-Operative Support: Following heart surgery, some patients may require short-term circulatory assistance to allow for proper healing and recovery.

Short Term Mechanical Circulatory Market, By End-User

• Hospitals: The primary users of short-term mechanical circulatory support devices are hospitals, particularly those with advanced cardiac care units and cardiothoracic surgery programs.
• Ambulatory Surgical Centers: In some cases, minimally invasive procedures using certain short-term circulatory support devices might be performed in ambulatory surgical centers.
• Specialty Clinics: Certain specialty clinics focusing on heart failure management or advanced heart conditions might utilize short-term circulatory support devices for specific procedures or patient needs.

Short Term Mechanical Circulatory Market, By Geography

• North America: Market conditions and demand in the United States, Canada, and Mexico.
• Europe: Analysis of the Short Term Mechanical Circulatory Market in European countries.
• Asia-Pacific: Focusing on countries like China, India, Japan, South Korea, and others.
• Middle East and Africa: Examining market dynamics in the Middle East and African regions.
• Latin America: Covering market trends and developments in countries across Latin America.

Key Players

• The major players in the Short Term Mechanical Circulatory Market are:
• Abiomed
• Medtronic
• SynCardia
• Berlin Heart GmbH
• CardiacAssist Inc.
• Jarvik Heart Inc.
• MicroMed Cardiovascular Inc.
• ReliantHeart Inc.
• Thoratec Corporation
• CHF Solutions

TABLE OF CONTENTS

1. Introduction

• Market Definition
• Market Segmentation
• Research Methodology

2. Executive Summary

• Key Findings
• Market Overview
• Market Highlights

3. Market Overview

• Market Size and Growth Potential
• Market Trends
• Market Drivers
• Market Restraints
• Market Opportunities
• Porter's Five Forces Analysis

4. Short Term Mechanical Circulatory Market, By Product

• Intra-aortic Balloon Pumps (IABPs)
• Percutaneous Ventricular Assist Devices (pVADs)
• Extracorporeal Membrane Oxygenation (ECMO)
• Other Devices

5. Short Term Mechanical Circulatory Market, By Therapy

• Cardiogenic Shock
• Acute Heart Failure
• Post-Operative Support

6. Short Term Mechanical Circulatory Market, By End-User

• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics

7. Regional Analysis

• North America
• United States
• Canada
• Mexico
• Europe
• United Kingdom
• Germany
• France
• Italy
• Asia-Pacific
• China
• Japan
• India
• Australia
• Latin America
• Brazil
• Argentina
• Chile
• Middle East and Africa
• South Africa
• Saudi Arabia
• UAE

8. Market Dynamics

• Market Drivers
• Market Restraints
• Market Opportunities
• Impact of COVID-19 on the Market

9. Competitive Landscape

• Key Players
• Market Share Analysis

10. Company Profiles

• Abiomed
• Medtronic
• SynCardia
• Berlin Heart GmbH
• CardiacAssist Inc.
• Jarvik Heart Inc.
• MicroMed Cardiovascular Inc.
• ReliantHeart Inc.
• Thoratec Corporation
• CHF Solutions

11. Market Outlook and Opportunities

• Emerging Technologies
• Future Market Trends
• Investment Opportunities

12. Appendix

• List of Abbreviations
• Sources and References